Astrana Health Files 8-K on Financials

Ticker: ASTH · Form: 8-K · Filed: Aug 7, 2025 · CIK: 1083446

Astrana Health, INC. 8-K Filing Summary
FieldDetail
CompanyAstrana Health, INC. (ASTH)
Form Type8-K
Filed DateAug 7, 2025
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

Astrana Health dropped an 8-K detailing financials - check it out.

AI Summary

Astrana Health, Inc. filed an 8-K on August 7, 2025, reporting on its Results of Operations and Financial Condition, and Financial Statements and Exhibits. The company, formerly known as Apollo Medical Holdings, Inc., is incorporated in Delaware and headquartered in Alhambra, California.

Why It Matters

This filing provides investors with crucial updates on Astrana Health's financial performance and condition, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual events or risks.

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K?

This 8-K reports on the 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' of Astrana Health, Inc.

When was this 8-K filed?

The 8-K was filed on August 7, 2025.

What is Astrana Health, Inc.'s former company name?

Astrana Health, Inc.'s former company name was Apollo Medical Holdings, Inc.

Where is Astrana Health, Inc. headquartered?

Astrana Health, Inc. is headquartered at 1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801.

What is the company's state of incorporation?

Astrana Health, Inc. is incorporated in Delaware.

Filing Stats: 563 words · 2 min read · ~2 pages · Grade level 9.5 · Accepted 2025-08-07 16:14:33

Filing Documents

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On August 7, 2025, Astrana Health, Inc. (the "Company") issued a press release announcing its financial results for the three and six months ended June 30, 2025. A copy of the press release and supplemental data is furnished with this Current Report on Form 8-K as Exhibit 99.1 and Exhibit 99.2 , respectively, and incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information furnished pursuant to this Item 2.02, including Exhibit 99.1 and Exhibit 99.2 furnished herewith, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Astrana Health, Inc. Regarding its Financial Results for the Three and Six Months Ended June 30, 2025, dated August 7, 2025. 99.2 Supplemental Data of Astrana Health, Inc., dated August 7, 2025. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASTRANA HEALTH, INC. Date:August 7, 2025 By: /s/ Brandon K. Sim Name: Brandon K. Sim Title: Chief Executive Officer and President

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing